References
- Craighead, J. E., Abraham, J. L., Churg, A., Green, F. H. Y., Kleinerman, J., Pratt, P. C., Seemayer, A., Vallyathan, V., and Weill, H. 1982. The pathology of asbestos associated diseases of the lungs and pleural cavities: Diagnostic criteria and proposed grading schema. Arch. Pathol. Lab. Med. 106:544–596.
- Ding, M., Dong, Z., Chen, F., Pack, D., Ma, W. Y., Ye, J., Shi, X., Castranova, V., and Vallyathan, V. 1999a. Asbestos induces activator protein-1 (AP-1) transactivation in transgenic mice. Cancer Res. 59:1884–1889.
- Ding, M., Shi, X., Dong, Z., Chen, F., Lu, Y. J., Castranova, V., and Vallyathan, V. 1999b. Freshly fractured crystalline silica induces activator protein-1 activation through ERKs and p38 MAPK. J. Biol. Chem. 274:30611–30616.
- Driscoll, K. E., Deyo, L. C., Carter, J. M., Howard, B. W., Hassenbein, D. G., and Bertram, T. A. 1997. Effects of particle exposure and particle-elicited inflammatory cells on mutation in rat alveolar epithelial cells. Carcinogenesis 18:423–430.
- Mossman, B. T., and Churg, A. 1998. Mechanisms in the pathogenesis of asbestosis and silicosis. Am. J. Respir. Crit. Care Med. 157:1666–1680.
- Mossman, B. T., Faux, S., Janssen, Y., Jimenez, L. A., Timblin, C., Zanella, C., Goldberg, J., Walsh, E., Barchowsky, A., and Driscoll, K. 1997. Cell signaling pathways elicited by asbestos. Environ. Health Perspect. 105:1121–1125.
- Shi, X., Ding, M., Dong, Z., Chen, F., Ye, J., Wang, S., Leonard, S. S., Castranova, V., and Vallyathan, V. 1999. Antioxidant properties of aspirin: Characterization of the ability of aspirin to inhibit silica-induced lipid peroxidation, DNA damage, NF-κB activation and TNF-α production. Mol. Cell. Biochem. 199:93–102.
- Vallyathan, V., Shi, X., and Castranova, V. 1998. Reactive oxygen species: Their relation to pneumoconiosis and carcinogenesis. Environ. Health Perspect. 106:1151–1155.